Non-Opioid Pharmacotherapy for Treatment of Pediatric Chronic Pain

David J. Krodel

doi:10.1007/978-3-030-36287-4_17

Non-Opioid Pharmacotherapy for Treatment of Pediatric Chronic Pain

David J. Krodel^*

^*Corresponding author for this work

Anesthesiology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Opioid therapy is prescribed to children and adolescents with chronic pain due to lack of effective alternatives, insufficient understanding of nonopioid pharmacotherapy of chronic pain, and minimization of perceived risks of chronic opioid therapy in children and adolescents. Further exacerbating this problem, there are no FDA-approved indications for chronic pain for any nonopioid medication for patients under 18 years of age. Only a handful of medications commonly used for chronic pain have FDA approval for any indication in the under-18 population. Due to the paucity of well-conducted randomized controlled trials, adult data, empiricism, and provider-patient-family preferences guide the prescribing of these medications.

Original language	English (US)
Title of host publication	Opioid Therapy in Infants, Children, and Adolescents
Publisher	Springer International Publishing
Pages	297-312
Number of pages	16
ISBN (Electronic)	9783030362874
ISBN (Print)	9783030362867
DOIs	https://doi.org/10.1007/978-3-030-36287-4_17
State	Published - Jan 1 2020

Keywords

Adolescent pain
Nonmalignant chronic pain
Nonopioid pain therapy
Pediatric chronic pain
Pediatric opioid therapy

ASJC Scopus subject areas

General Medicine
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1007/978-3-030-36287-4_17

Cite this

@inbook{dc10df3692f14928b0c8d96f36ffc4ac,

title = "Non-Opioid Pharmacotherapy for Treatment of Pediatric Chronic Pain",

abstract = "Opioid therapy is prescribed to children and adolescents with chronic pain due to lack of effective alternatives, insufficient understanding of nonopioid pharmacotherapy of chronic pain, and minimization of perceived risks of chronic opioid therapy in children and adolescents. Further exacerbating this problem, there are no FDA-approved indications for chronic pain for any nonopioid medication for patients under 18 years of age. Only a handful of medications commonly used for chronic pain have FDA approval for any indication in the under-18 population. Due to the paucity of well-conducted randomized controlled trials, adult data, empiricism, and provider-patient-family preferences guide the prescribing of these medications.",

keywords = "Adolescent pain, Nonmalignant chronic pain, Nonopioid pain therapy, Pediatric chronic pain, Pediatric opioid therapy",

author = "Krodel, {David J.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2020.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-36287-4_17",

language = "English (US)",

isbn = "9783030362867",

pages = "297--312",

booktitle = "Opioid Therapy in Infants, Children, and Adolescents",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Non-Opioid Pharmacotherapy for Treatment of Pediatric Chronic Pain

AU - Krodel, David J.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2020.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Opioid therapy is prescribed to children and adolescents with chronic pain due to lack of effective alternatives, insufficient understanding of nonopioid pharmacotherapy of chronic pain, and minimization of perceived risks of chronic opioid therapy in children and adolescents. Further exacerbating this problem, there are no FDA-approved indications for chronic pain for any nonopioid medication for patients under 18 years of age. Only a handful of medications commonly used for chronic pain have FDA approval for any indication in the under-18 population. Due to the paucity of well-conducted randomized controlled trials, adult data, empiricism, and provider-patient-family preferences guide the prescribing of these medications.

AB - Opioid therapy is prescribed to children and adolescents with chronic pain due to lack of effective alternatives, insufficient understanding of nonopioid pharmacotherapy of chronic pain, and minimization of perceived risks of chronic opioid therapy in children and adolescents. Further exacerbating this problem, there are no FDA-approved indications for chronic pain for any nonopioid medication for patients under 18 years of age. Only a handful of medications commonly used for chronic pain have FDA approval for any indication in the under-18 population. Due to the paucity of well-conducted randomized controlled trials, adult data, empiricism, and provider-patient-family preferences guide the prescribing of these medications.

KW - Adolescent pain

KW - Nonmalignant chronic pain

KW - Nonopioid pain therapy

KW - Pediatric chronic pain

KW - Pediatric opioid therapy

UR - http://www.scopus.com/inward/record.url?scp=85149492904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149492904&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-36287-4_17

DO - 10.1007/978-3-030-36287-4_17

M3 - Chapter

AN - SCOPUS:85149492904

SN - 9783030362867

SP - 297

EP - 312

BT - Opioid Therapy in Infants, Children, and Adolescents

PB - Springer International Publishing

ER -

Non-Opioid Pharmacotherapy for Treatment of Pediatric Chronic Pain

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this